Bio Works (Sweden) Buy Hold or Sell Recommendation
| BIOWKS Stock | SEK 1.55 0.13 9.15% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Bio Works Technologies AB is 'Hold'. Macroaxis provides Bio Works buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BIOWKS positions.
Check out Bio Works Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Bio and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Bio Works Technologies AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
Bio |
Execute Bio Works Buy or Sell Advice
The Bio recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Bio Works Technologies AB. Macroaxis does not own or have any residual interests in Bio Works Technologies AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Bio Works' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Solid | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Bio Works Trading Alerts and Improvement Suggestions
| Bio Works is way too risky over 90 days horizon | |
| Bio Works may become a speculative penny stock | |
| Bio Works appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 21.91 M. Net Loss for the year was (12.94 M) with profit before overhead, payroll, taxes, and interest of 53.01 M. | |
| Bio Works Technologies AB has accumulated about 46.35 M in cash with (13.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.4, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 55.0% of the company shares are held by company insiders |
Bio Works Returns Distribution Density
The distribution of Bio Works' historical returns is an attempt to chart the uncertainty of Bio Works' future price movements. The chart of the probability distribution of Bio Works daily returns describes the distribution of returns around its average expected value. We use Bio Works Technologies AB price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Bio Works returns is essential to provide solid investment advice for Bio Works.
| Mean Return | 0.96 | Value At Risk | -5.95 | Potential Upside | 9.52 | Standard Deviation | 4.98 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Bio Works historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Bio Works Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bio Works or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bio Works' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bio stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 1.01 | |
β | Beta against Dow Jones | 0.56 | |
σ | Overall volatility | 5.22 | |
Ir | Information ratio | 0.21 |
Bio Works Volatility Alert
Bio Works Technologies AB shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Bio Works' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Bio Works' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Bio Works Fundamentals Vs Peers
Comparing Bio Works' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Bio Works' direct or indirect competition across all of the common fundamentals between Bio Works and the related equities. This way, we can detect undervalued stocks with similar characteristics as Bio Works or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Bio Works' fundamental indicators could also be used in its relative valuation, which is a method of valuing Bio Works by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Bio Works to competition |
| Fundamentals | Bio Works | Peer Average |
| Return On Equity | -0.66 | -0.31 |
| Return On Asset | -0.35 | -0.14 |
| Profit Margin | (1.31) % | (1.27) % |
| Operating Margin | (1.27) % | (5.51) % |
| Current Valuation | 635.01 M | 16.62 B |
| Shares Outstanding | 34.87 M | 571.82 M |
| Shares Owned By Insiders | 54.85 % | 10.09 % |
| Shares Owned By Institutions | 5.59 % | 39.21 % |
| Price To Book | 8.03 X | 9.51 X |
| Price To Sales | 19.71 X | 11.42 X |
| Revenue | 21.91 M | 9.43 B |
| Gross Profit | 53.01 M | 27.38 B |
| EBITDA | (8.6 M) | 3.9 B |
| Net Income | (12.94 M) | 570.98 M |
| Cash And Equivalents | 46.35 M | 2.7 B |
| Cash Per Share | 2.40 X | 5.01 X |
| Current Ratio | 9.14 X | 2.16 X |
| Book Value Per Share | 2.55 X | 1.93 K |
| Cash Flow From Operations | (13.37 M) | 971.22 M |
| Earnings Per Share | (0.41) X | 3.12 X |
| Target Price | 27.0 | |
| Number Of Employees | 36 | 18.84 K |
| Beta | 0.99 | -0.15 |
| Market Capitalization | 718.4 M | 19.03 B |
| Total Asset | 120.86 M | 29.47 B |
| Net Asset | 120.86 M |
Bio Works Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Bio . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Bio Works Buy or Sell Advice
When is the right time to buy or sell Bio Works Technologies AB? Buying financial instruments such as Bio Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Bio Works in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Entertainment Thematic Idea Now
Entertainment
Companies from entertainment industry including show business, news and media. The Entertainment theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Entertainment Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Bio Stock
Bio Works financial ratios help investors to determine whether Bio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bio with respect to the benefits of owning Bio Works security.